BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.7B
AUM Growth
-$908M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
107
New
Increased
Reduced
Closed

Top Buys

1
+$66.6M
2
+$56.3M
3
+$29.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$26.7M
5
HRTX icon
Heron Therapeutics
HRTX
+$18.6M

Top Sells

1
+$195M
2
+$97.2M
3
+$68.7M
4
GHDX
Genomic Health, Inc.
GHDX
+$54.6M
5
ARRY
Array Biopharma Inc
ARRY
+$46M

Sector Composition

1 Healthcare 94.63%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$57M 0.39%
1,506,438
-208,745
27
$56.3M 0.38%
+1,165,411
28
$54.5M 0.37%
14,382,673
-735,408
29
$54.2M 0.37%
1,801,695
+978,582
30
$51M 0.35%
1,016,306
31
$45.3M 0.31%
550,956
32
$41.7M 0.28%
1,034,674
+250,000
33
$40.9M 0.28%
5,707,411
34
$40.5M 0.28%
517,700
-87,300
35
$37.9M 0.26%
2,799,577
-200,423
36
$37.6M 0.26%
1,708,472
37
$25.8M 0.18%
546,708
38
$19.9M 0.14%
772,286
-427,714
39
$17.5M 0.12%
428,120
40
$17M 0.12%
1,160,014
41
$15.4M 0.1%
16,760
+14,326
42
$14.4M 0.1%
1,559,231
+1,053,991
43
$14M 0.1%
673,908
44
$12.3M 0.08%
271,202
-13,782
45
$12.1M 0.08%
995,082
+591,189
46
$11.9M 0.08%
150,000
47
$11.7M 0.08%
68,544
48
$10.8M 0.07%
66,937
+54,555
49
$10.8M 0.07%
999,823
50
$9.83M 0.07%
2,559,461
-340,539
1
2
3 4 5